Found: 38
Select item for more details and to access through your institution.
Trends in three major histological subtypes of cutaneous melanoma in the Netherlands between 1989 and 2016.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 4, p. 508, doi. 10.1111/ijd.16559
- By:
- Publication type:
- Article
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis.
- Published in:
- Drugs, 2024, v. 84, n. 5, p. 565, doi. 10.1007/s40265-024-02028-1
- By:
- Publication type:
- Article
Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02545-4
- By:
- Publication type:
- Article
Blood-Based Immune Profiling Combined with Machine Learning Discriminates Psoriatic Arthritis from Psoriasis Patients.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 10990, doi. 10.3390/ijms222010990
- By:
- Publication type:
- Article
Zorg op afstand in de dermatologie Wat zijn de consequenties voor patiënten, zorgverleners en de maatschappij?
- Published in:
- Tijdschrift voor Human Factors, 2023, v. 48, n. 3, p. 5
- By:
- Publication type:
- Article
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1594, doi. 10.1007/s12325-023-02759-9
- By:
- Publication type:
- Article
Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 6, p. 616, doi. 10.1001/jamadermatol.2014.5479
- By:
- Publication type:
- Article
Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-up.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis One-Year Follow-up.
- Published in:
- JAMA Dermatology, 2014, v. 150, n. 2, p. 130, doi. 10.1001/jamadermatol.2013.8347
- By:
- Publication type:
- Article
O01 Clinical aspects of psoriasis flares and risk factors for developing a post-infectious flare in children with SARS-CoV-2 infection: data from the Chi-PsoCov registry.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 3, p. e40, doi. 10.1093/bjd/ljad259.001
- By:
- Publication type:
- Article
Should we prefer biologics over nonbiological agents in psoriasis?
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 3, p. 258, doi. 10.1093/bjd/ljad231
- By:
- Publication type:
- Article
Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 6, p. 1028, doi. 10.1111/bjd.21797
- By:
- Publication type:
- Article
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study.
- Published in:
- Acta Dermato-Venereologica, 2020, v. 100, n. 12, p. 1, doi. 10.2340/00015555-3692
- By:
- Publication type:
- Article
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study.
- Published in:
- Acta Dermato-Venereologica, 2019, v. 99, n. 4, p. 386, doi. 10.2340/00015555-3108
- By:
- Publication type:
- Article
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study.
- Published in:
- Acta Dermato-Venereologica, 2018, v. 98, n. 7, p. 648, doi. 10.2340/00015555-2900
- By:
- Publication type:
- Article
Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
- Published in:
- Acta Dermato-Venereologica, 2017, v. 97, n. 6, p. 724, doi. 10.2340/00015555-2637
- By:
- Publication type:
- Article
Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized Scleroderma.
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 7, p. 943, doi. 10.2340/00015555-2411
- By:
- Publication type:
- Article
Effectiveness of Biologic and Conventional Systemic Therapies in Adults with Chronic Plaque Psoriasis in Daily Practice: A Systematic Review.
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 4, p. 453, doi. 10.2340/00015555-2276
- By:
- Publication type:
- Article
Prevalence of chronic urticaria and healthcare usage of patients with the condition in primary care: a population-based study in the Netherlands.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 2, p. 287, doi. 10.1093/bjd/ljad426
- By:
- Publication type:
- Article
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.17752
- By:
- Publication type:
- Article
Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.5269
- By:
- Publication type:
- Article
Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.2225
- By:
- Publication type:
- Article
Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.685
- By:
- Publication type:
- Article
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factoralpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.175
- By:
- Publication type:
- Article
Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 5, p. 1, doi. 10.2340/00015555-3815
- By:
- Publication type:
- Article
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 7, p. e34, doi. 10.1038/jid.2015.171
- By:
- Publication type:
- Article
The Effect of Lifestyle Changes on Disease Severity and Quality of Life in Patients with Plaque Psoriasis: A Narrative Review.
- Published in:
- Psoriasis: Targets & Therapy, 2022, v. 12, p. 35, doi. 10.2147/PTT.S294189
- By:
- Publication type:
- Article
The Skin May Clear But the Arthritis Won't Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy.
- Published in:
- Psoriasis: Targets & Therapy, 2020, v. 10, p. 29, doi. 10.2147/PTT.S270619
- By:
- Publication type:
- Article
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 9, p. 1815, doi. 10.1111/jdv.19089
- By:
- Publication type:
- Article
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study-the BeNeBio study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association of HLA-C*06:02 Status With Differential Response to Ustekinumab in Patients With Psoriasis: A Systematic Review and Meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article